Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06470659 · ClinicalTrials.gov registry record · NA

Medications With or Without WeightWatchers

A NA study of Obesity and Overweight, sponsored by Michelle Cardel, PhD, MS, RD.

Completed
Registry status
NA
Development phase
101
Enrollment target
1
Study location

NCT06470659 is a NA study of Obesity and Overweight that has completed, run by Michelle Cardel, PhD, MS, RD. The registered enrollment target is 101 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06470659, a NA study of Obesity and Overweight, has completed, sponsored by Michelle Cardel, PhD, MS, RD.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target
1
Study location

Study Summary

The study compares the effectiveness of adults living with overweight or obesity taking weight management medications alone vs taking them with behavioral and lifestyle support. The primary outcome is percent body weight lost at 12-weeks.

Conditions Studied

Interventions

  • BEHAVIORAL WW Clinic

Study Locations (1)

New York

  • WW International, Inc - New York

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2024-06-17
Est. Completion 2025-01-28
Phase NA

Sponsor

Michelle Cardel, PhD, MS, RD

1 total trials

What the Registry Record Tells You About NCT06470659

The ClinicalTrials.gov registry entry for NCT06470659 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The listed sponsor is Michelle Cardel, PhD, MS, RD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which WW Clinic is the first listed.

NCT06470659 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06470659 about?

NCT06470659 is a clinical study titled "Medications With or Without WeightWatchers". The study compares the effectiveness of adults living with overweight or obesity taking weight management medications alone vs taking them with behavioral and lifestyle support. The primary outcome is percent body weight lost at 12-weeks.

What is the current status of trial NCT06470659?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2024-06-17. Estimated completion is 2025-01-28.

What conditions does trial NCT06470659 study?

This clinical trial studies the following conditions: Obesity, Overweight.

What interventions are being tested in trial NCT06470659?

The interventions under investigation include: WW Clinic (BEHAVIORAL).

Who is sponsoring clinical trial NCT06470659?

This trial is sponsored by Michelle Cardel, PhD, MS, RD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06470659 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.